losartan-potassium and deoxypyridinoline

losartan-potassium has been researched along with deoxypyridinoline* in 1 studies

Other Studies

1 other study(ies) available for losartan-potassium and deoxypyridinoline

Article	Year
Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice. Scientific reports, 2019, 10-18, Volume: 9, Issue:1 Fibroblast Growth Factor 23 (FGF23) is a phosphaturic factor causing increased renal phosphate excretion as well as suppression of 1,25 (OH) Topics: Amino Acids; Animals; Bone Density; Calcification, Physiologic; Calcitriol; Calcium; Erythropoietin; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Kidney; Mice; Mice, Inbred C57BL; Mice, Transgenic; Minerals; Osteocalcin; Phosphates; Renal Insufficiency, Chronic	2019

Article

Year

Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice.

Scientific reports, 2019, 10-18, Volume: 9, Issue:1

Fibroblast Growth Factor 23 (FGF23) is a phosphaturic factor causing increased renal phosphate excretion as well as suppression of 1,25 (OH)

Topics: Amino Acids; Animals; Bone Density; Calcification, Physiologic; Calcitriol; Calcium; Erythropoietin; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Kidney; Mice; Mice, Inbred C57BL; Mice, Transgenic; Minerals; Osteocalcin; Phosphates; Renal Insufficiency, Chronic

2019